Below are sample transactions closed by Extera:

• $130M Merger of a US-based biopharmaceutical company
• $30M indication-splitting biopharmaceutical license transaction
• Multi-million Euro PIPE into public European medical device company
• Multi-million Euro private placement into European medical device company
• Angel funding for early stage US based biotech
• Distribution deal with one of the largest US distribution organization
• Strategic collaboration with large research tool companies
• Multiple supply and manufacturing deals